Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Altcheh

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
British Journal of Clinical Pharmacology|August 30, 2024
Adverse events associated with benznidazole treatment for Chagas disease in children and adultsCintia Valeria Cruz, Andres Rabinovich, Guillermo Moscatelli, et al.
Plos Neglected Tropical Diseases|January 18, 2024
An α-Gal antigenic surrogate as a biomarker of treatment evaluation in Trypanosoma cruzi-infected children. A retrospective cohort studyManuel Abal, Virginia Balouz, Rosana Lopez, et al.
Acta Tropica|June 30, 2020
In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection modelsJulián Ernesto Nicolás Gulin, Mackenzie Anne Eagleson, Rodrigo A López-Muñoz, et al.
Archivos Argentinos De Pediatria|November 14, 2022
[Patient with pulmonary cysts and diagnosis of co-infection with tuberculosis and hydatidosis. Pediatric cases report]Victoria Portillo, Federico Paruelo, Virginia Olivar, et al.
Plos Neglected Tropical Diseases|January 7, 2021
Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO)Jaime Altcheh, Luis Castro, Juan C Dib, et al.
Plos Neglected Tropical Diseases|August 16, 2019
Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas DiseaseSamanta Moroni, Maria Elena Marson, Guillermo Moscatelli, et al.
Archivos Argentinos De Pediatria|July 12, 2016
[Publication of abstracts presented at the National Pediatric Research Meetings of the Argentine Society of Pediatrics: Related factors]Paula Domínguez, María F Ossorio, Eduardo Cuestas, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 12, 2013
LMP1 promoter sequence analysis in Epstein Barr virus pediatric infection reveals preferential circulation of B95.8 related variants in ArgentinaMagdalena Gantuz, Mario Alejandro Lorenzetti, Jaime Altcheh, et al.
Diagnostic Microbiology and Infectious Disease|July 8, 2017
Rapid detection of Trypanosoma cruzi by colorimetric loop-mediated isothermal amplification (LAMP): A potential novel tool for the detection of congenital Chagas infectionRocío Rivero, Margarita Bisio, Elsa Beatriz Velázquez, et al.
Archivos Argentinos De Pediatria|July 5, 2012
[Pulmonary Hydatidosis]Guillermo Moscatelli, Zulma Abraham, Samanta Moroni, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
British Journal of Clinical Pharmacology|August 30, 2024
Adverse events associated with benznidazole treatment for Chagas disease in children and adultsCintia Valeria Cruz, Andres Rabinovich, Guillermo Moscatelli, et al.
Plos Neglected Tropical Diseases|January 18, 2024
An α-Gal antigenic surrogate as a biomarker of treatment evaluation in Trypanosoma cruzi-infected children. A retrospective cohort studyManuel Abal, Virginia Balouz, Rosana Lopez, et al.
Acta Tropica|June 30, 2020
In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection modelsJulián Ernesto Nicolás Gulin, Mackenzie Anne Eagleson, Rodrigo A López-Muñoz, et al.
Archivos Argentinos De Pediatria|November 14, 2022
[Patient with pulmonary cysts and diagnosis of co-infection with tuberculosis and hydatidosis. Pediatric cases report]Victoria Portillo, Federico Paruelo, Virginia Olivar, et al.
Plos Neglected Tropical Diseases|January 7, 2021
Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO)Jaime Altcheh, Luis Castro, Juan C Dib, et al.
Plos Neglected Tropical Diseases|August 16, 2019
Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas DiseaseSamanta Moroni, Maria Elena Marson, Guillermo Moscatelli, et al.
Archivos Argentinos De Pediatria|July 12, 2016
[Publication of abstracts presented at the National Pediatric Research Meetings of the Argentine Society of Pediatrics: Related factors]Paula Domínguez, María F Ossorio, Eduardo Cuestas, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 12, 2013
LMP1 promoter sequence analysis in Epstein Barr virus pediatric infection reveals preferential circulation of B95.8 related variants in ArgentinaMagdalena Gantuz, Mario Alejandro Lorenzetti, Jaime Altcheh, et al.
Diagnostic Microbiology and Infectious Disease|July 8, 2017
Rapid detection of Trypanosoma cruzi by colorimetric loop-mediated isothermal amplification (LAMP): A potential novel tool for the detection of congenital Chagas infectionRocío Rivero, Margarita Bisio, Elsa Beatriz Velázquez, et al.
Archivos Argentinos De Pediatria|July 5, 2012
[Pulmonary Hydatidosis]Guillermo Moscatelli, Zulma Abraham, Samanta Moroni, et al.
Pageof 9